Article
New actin mutants allow further characterization of the nucleotide binding cleft and drug binding sites.
Journal of cell science - 1 May 1999
Belmont L D, Patterson G M, Drubin D G
Abstract excerpt
We have generated 9 site-specific mutations in Saccharomyces cerevisiae actin. These mutants display a variety of phenotypes when expressed in vivo, including slow actin filament turnover, slow fluid-phase endocytosis, and defects in actin organization. Actin mutation D157E confers resistance to the actin-sequestering drug, latrunculin A. Latrunculin A inhibits nucleotide exchange on wild-type yeast actin but not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
